January 8, 2019 to January 10, 2019
USCAP Interactive Center, Palm Springs, CA
Laura C. Collins, M.D.
Beth Israel Deaconess Medical Center / Harvard Medical School
Dr. Laura Collins is the Director of Anatomic Pathology at Beth Israel Deaconess Medical Center (BIDMC) and Professor of Pathology at Harvard Medical School in Boston. She has previously served as the Program Director of both the Residency and Selective Pathology Fellowship Training Programs at BIDMC. Dr. Collins earned her medical degree from the Charing Cross and Westminster Medical School in London, UK. She completed a residency in Anatomic and Clinical Pathology and Cytology Fellowship at BIDMC. Dr. Collins' research, teaching and clinical activities are focused on diseases of the breast. She is a member of the USCAP Board of Directors and current President of the Arthur Purdy Stout Society.
Kimberly H. Allison, M.D.
Stanford University School of Medicine
Dr. Allison is the Director of Breast Pathology at Stanford University School of Medicine. She earned a B.A. from Princeton University in Molecular Biology, an M.D. from New York Medical College, and certification in anatomical and clinical pathology from the American Board of Pathology. Her residency and fellowship training were completed at the University of Washington Medical Center. She has a special interest in the development of high quality diagnostic standards and is active in setting practice guidelines, such as the CAP/ASCO HER2 Testing Breast Cancer Guidelines. She is highly involved in educating the next generation of pathologists as Program Director for Stanford Pathology Residency Program and Director of the Stanford Breast Pathology Fellowship. Dr. Allison has also experienced "the other side of the microscope" as a breast cancer patient; an experience which inspired her to publish her memoir, "Red Sunshine," and advocate for public awareness of pathology's role in cancer care.
Timothy M. D’Alfonso, M.D.
Memorial Sloan Kettering Cancer Center
Dr. D'Alfonso is an Associate Attending Pathologist at Memorial Sloan Kettering Cancer Center with clinical and research interests focused on diseases of the breast, including breast cancer. Dr. D'Alfonso earned his medical degree from Rosalind Franklin University of Medicine and Science/Chicago Medical School. He completed residency training in Anatomic Pathology followed by a fellowship in Breast Pathology at NewYork-Presbyterian Hospital/Weill Cornell Medicine. He was a member of the faculty at Weill Cornell Medicine as an Instructor and Assistant Professor of Pathology and Laboratory Medicine, where he served as Director of the Breast Pathology Fellowship Program. Dr. D'Alfonso has published several peer-reviewed journal articles and textbook chapters on the subject of breast pathology. He is an ad hoc reviewer for numerous journals and has served as an abstract reviewer for USCAP. He has lectured in courses at national pathology conferences, including USCAP, ASCP, and CAP annual meetings.
Deborah Dillon, M.D.
Harvard Medical School
Dr. Dillon graduated from Yale Medical School, trained in Anatomic and Molecular Pathology at Yale-New Haven Hospital and is currently Assistant Professor of Pathology at Harvard Medical School. While at Yale, she received her subspecialty training in Breast Pathology with Dr. Darryl Carter and was board-certified in Molecular Genetic Pathology. She has worked as a breast and molecular pathologist for 20 years and has been a member of the Brigham and Women's Hospital Breast Group since 2004. She teaches breast pathology to trainees, pathologists and clinicians locally, nationally and internationally. She is a past Chair of the Solid Tumor Subdivision of the Association for Molecular Pathology, past member of the College of American Pathologists Steering Committee for Biomarker Reporting and a co-author of the CAP Template for Reporting Results of Biomarker Testing in Breast Cancer. She serves as an ad hoc reviewer for numerous journals and is a Section Editor for Archives of Pathology and Laboratory Medicine. She has published more than 50 articles, books and book chapters related to breast pathology. In addition to clinical work in breast and molecular pathology, Dr. Dillon is also an active collaborator with basic scientists in the evaluation of new markers for breast cancer and new techniques for molecular analysis. She serves as Director of the Dana Farber/Harvard Cancer Center Breast Tissue Bank and Translational Research Laboratory, Co-Director of the Pathology Core for the DFCI Breast SPORE and works closely with breast oncologists in biomarker evaluation for clinical trials.